Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CMO DUH!
hmmmm 2/9 is in 2 days and people are selling...
Yea right... nice try MM's!!!
You mean you didn't ask Leo at the conference?
PR this week on K Ovarian trial start.
Anticipated Study Start Date: February 9, 2017
Look out shorts!!!
day late..
Ya mean where Keytruda and Opdivo can attack healthy organs during and after treatment and may cause death?
10-12 exactly...and Apparently it doesn't work on Ovarian cancer either as a mono therapy.
Can't wait for the next monthly Conference Call from the 3 trials sites for UP at 100MG!
Awesome feedback so far.
MERCK(KEYTRUDA) are currently running 3 trials for ovarian cancer
using Keytruda in combo with old existing drugs.
Keytruda/Paclitaxel
Keytruda/Gemcitabine
Keytruda/Cisplatin
I guess they have a BIG interest in OVARIAN cancer!!!!!
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!
Starting week 14 of Prurisol trial.
1st week of patients have complated their 12 weeks of dosing.
Can't wait for 6 week data...
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!
Somebody is waiting in the Wings for This short Kevetrin trial results.
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO!!
Our near-term focus is now on preparing for a Phase 2a trial of Kevetrin in treating late-stage ovarian cancer, which we anticipate will start in the fourth quarter this year,” said Cellceutix President and Chief Medical Officer Dr. Arthur P. Bertolino. “This will be a small trial that will move quickly with the end goal to provide the critical data necessary to forge a partnership with a large pharmaceutical company interested in co-developing Kevetrin as it makes progress toward possibly becoming the first p53-activating drug approved by the FDA.”
Maybe "A Potential Partner"
wanted to see an all "K" trial.
All questions answered by a K only trial. No guessing if it was K or the other drug..
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!!
and if Leo ran the combo trial
these goofs would be saying that the other drug caused the tumor shrinkage NOT KEVETRIN.
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!
AND THEY KNOW IT!!!!!!!!!!!!!!!!!!
$10,200,000,000.!!!!!
A little Cellceutix Website reading...
http://www.cellceutix.com/new-blog/2016/10/5/the-social-stigma-of-psoriasis-1
DR. Jerry You have been away to long.
505 doesn't require a large phase3.
300 patients will suffice...
It sure is when you consider the Placebo effect didn't start until "8" weeks of treatment in the ph2.........
KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!
Visual meaning seen by clinical site personnel. Sheeeesh!
ALL current visual reports of Psoriasis clearing in 2B patients at or before 6 weeks is clearly Prurisol and Prurisol alone.....NOT Placebo...
CTIX is heating up!
TIC TOC
KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!
Why didn't they do a 6 weeker for phase2?
Why a 6 week data readout...Hmmmmmmmm?
Blues44 I forgot you are a fan of that cf1 whatever it's called oral psoriasis drug that works after 32 weeks...Hey good luck with that.
I think they all get positive results...
Read clinicaltrials.org sheeeesh
yea Karin I know. 1050 weekly-750 weekly=300mg more a week.
What part didn't you understand?
BP wants that 6 week data BADLY!
Can you image if some Prurisol patients achieve 0/1 after only 6 weeks?
KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!!!!!!
1050mg a week in cohort 2 is 300mg more than the highest dose given in Phase1.
I think Menon said screw the combo therapy we will just up the K dosage!
Simply WOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOW!!!
Is this K O trial for stage 4 patients only as Phase 1 was?
Inclusion criteria in phase1 was life expectancy >3 months. Phase 2a 6>.
Interesting......
I like that Leo didn't tell us the protocol for K was submitted to the FDA....
It keeps the you know who guessing...
NR who cares.....The only people who know about OC trial are message board people.
Lets wait for the PR(next week)......
That was an honest mistake
Bunny just had the decimal point in the wrong place.
K OC has orphan designation...So yes you missed something....
OM has Fast Track Designation.....sheeeesh
How bout Breakthrough Therapy?
KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO!!
Cabel You would give a dying woman water in her IV?
dern but I was closer!!!
Do you realize that we could have
final results for
Prurisol 2b
UP 2a
K 2a
all in June/July?
Not to mention interim OM results in March...
OMG!!!
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!
That was for Pancreatic....sheeeeeesh!
TIAB ONLY 10 patients!!!!!
LMAO!!!!!